- Home
- RMCO vs ABVC Comparison
RMCO vs ABVC Comparison
Compare RMCO & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RMCO | ABVC |
|---|---|---|
| Founded | 2021 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Multi-Sector Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.3M | 35.6M |
| IPO Year | N/A | 2009 |
Fundamental Metrics
Financial Performance| Metric | RMCO | ABVC |
|---|---|---|
| Price | $2.62 | $1.44 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 36.9K | ★ 115.0K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | ★ 0.35% | N/A |
| EPS Growth | N/A | ★ 7.14 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $509,589.00 |
| Revenue This Year | $209.10 | N/A |
| Revenue Next Year | $133.33 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.05 | $0.88 |
| 52 Week High | $5.00 | $4.02 |
Technical Indicators
Market Signals| Indicator | RMCO | ABVC |
|---|---|---|
| Relative Strength Index (RSI) | 51.06 | 62.00 |
| Support Level | $1.94 | $0.96 |
| Resistance Level | $3.14 | $1.46 |
| Average True Range (ATR) | 0.35 | 0.13 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 75.86 | 79.52 |
Price Performance
Historical ComparisonAbout RMCO Royalty Management Holding Corporation
Royalty Management Holding Corp is formed to invest or purchase assets that have near and medium-term income potential to provide RMC with accretive cash flow from which it can reinvest in new assets or expand cash flow from those existing assets. These assets typically are natural resources assets (including real estate and mining permits), patents, intellectual property, and emerging technologies.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.